Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADE Chemotherapy for Relapsed Childhood AML
NCT03053206Phase 2Unknown
- Sponsor
- AIIMS New Delhi
- Start
- Feb 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cytarabine, daunorubicin, etoposide in acute myeloid leukemia (AML), sponsored by AIIMS New Delhi. Status: unknown.
02
Drugs
cytarabinedaunorubicinetoposide
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT03053206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03053206.